These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1033 related articles for article (PubMed ID: 35490310)
1. Hydrazide-hydrazones as Small Molecule Tropomyosin Receptor Kina se A (TRKA) Inhibitors: Synthesis, Anticancer Activities, Alam MS; Lee DU Med Chem; 2022; 19(1):47-63. PubMed ID: 35490310 [TBL] [Abstract][Full Text] [Related]
2. Synthesis, anticancer, and docking studies of salicyl-hydrazone analogues: A novel series of small potent tropomyosin receptor kinase A inhibitors. Alam MS; Choi SU; Lee DU Bioorg Med Chem; 2017 Jan; 25(1):389-396. PubMed ID: 27856237 [TBL] [Abstract][Full Text] [Related]
3. Molecular Hybrid Design, Synthesis, In Vitro Cytotoxicity, In Silico ADME and Molecular Docking Studies of New Benzoate Ester-Linked Arylsulfonyl Hydrazones. Ergan E; Çakmak R; Başaran E; Mali SN; Akkoc S; Annadurai S Molecules; 2024 Jul; 29(15):. PubMed ID: 39124882 [TBL] [Abstract][Full Text] [Related]
4. Synthesis, biological evaluation, drug-likeness, and in silico screening of novel benzylidene-hydrazone analogues as small molecule anticancer agents. Alam MS; Lee DU Arch Pharm Res; 2016 Feb; 39(2):191-201. PubMed ID: 26694484 [TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, molecular docking, in silico ADMET profile and anticancer evaluations of sulfonamide endowed with hydrazone-coupled derivatives as VEGFR-2 inhibitors. Sayed AM; Taher FA; Abdel-Samad MRK; El-Gaby MSA; El-Adl K; Saleh NM Bioorg Chem; 2021 Mar; 108():104669. PubMed ID: 33515863 [TBL] [Abstract][Full Text] [Related]
6. Synthesis, in vitro anticancer activity and in silico studies of certain isoxazole-based carboxamides, ureates, and hydrazones as potential inhibitors of VEGFR2. Abou-Seri SM; Eissa AAM; Behery MGM; Omar FA Bioorg Chem; 2021 Nov; 116():105334. PubMed ID: 34534755 [TBL] [Abstract][Full Text] [Related]
7. Design, Synthesis, Anti-Proliferative, Anti-microbial, Anti-Angiogenic Activity and Ünver H; Berber B; Demirel R; Koparal AT Anticancer Agents Med Chem; 2019; 19(13):1658-1669. PubMed ID: 30887930 [TBL] [Abstract][Full Text] [Related]
8. Chemical Characterization, Ansari JA; Ahmad MK; Fatima N; Azad I; Mahdi AA; Satyanarayan GNV; Ahmad N Anticancer Agents Med Chem; 2022; 22(20):3416-3437. PubMed ID: 35125087 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of (Z)-2,3-diphenylacrylonitrile analogs as anti-cancer and anti-microbial agents. Alam MS; Nam YJ; Lee DU Eur J Med Chem; 2013 Nov; 69():790-7. PubMed ID: 24113364 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and Evaluation of 2-Naphthaleno trans-Stilbenes and Cyanostilbenes as Anticancer Agents. Madadi NR; Penthala NR; Ketkar A; Eoff RL; Trujullo-Alonso V; Guzman ML; Crooks PA Anticancer Agents Med Chem; 2018; 18(4):556-564. PubMed ID: 28403783 [TBL] [Abstract][Full Text] [Related]
11. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme. El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967 [TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, modeling studies and biological evaluation of pyrazole derivatives linked to oxime and nitrate moieties as nitric oxide donor selective COX-2 and aromatase inhibitors with dual anti-inflammatory and anti-neoplastic activities. A A Fadaly W; A M M Elshaier Y; T M Nemr M; R A Abdellatif K Bioorg Chem; 2023 May; 134():106428. PubMed ID: 36893546 [TBL] [Abstract][Full Text] [Related]
13. Computer-aided drug design and virtual screening of targeted combinatorial libraries of mixed-ligand transition metal complexes of 2-butanone thiosemicarbazone. Khan T; Ahmad R; Azad I; Raza S; Joshi S; Khan AR Comput Biol Chem; 2018 Aug; 75():178-195. PubMed ID: 29883916 [TBL] [Abstract][Full Text] [Related]
14. (E)-N-Aryl-2-oxo-2-(3,4,5-trimethoxyphenyl)acetohydrazonoyl cyanides as tubulin polymerization inhibitors: Structure-based bioisosterism design, synthesis, biological evaluation, molecular docking and in silico ADME prediction. Wang G; Peng Z; Peng S; Qiu J; Li Y; Lan Y Bioorg Med Chem Lett; 2018 Nov; 28(20):3350-3355. PubMed ID: 30197030 [TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and biological evaluation of aminopyridine derivatives as novel tropomyosin receptor kinase inhibitors. Lv R; Wang X; Sun Y; Qin Q; Liu N; Wu T; Sun Y; Yin W; Zhao D; Cheng M Arch Pharm (Weinheim); 2023 Mar; 356(3):e2200438. PubMed ID: 36398500 [TBL] [Abstract][Full Text] [Related]
16. New Anthranilic Acid Hydrazones as Fenamate Isosteres: Synthesis, Characterization, Molecular Docking, Dynamics & in Silico ADME, in Vitro Anti-Inflammatory and Anticancer Activity Studies. Şenol H; Çağman Z; Gençoğlu Katmerlikaya T; Sinan Tokalı F Chem Biodivers; 2023 Aug; 20(8):e202300773. PubMed ID: 37384873 [TBL] [Abstract][Full Text] [Related]
17. Synthesis, Antimicrobial - Cytotoxic Evaluation, and Molecular Docking Studies of Quinolin-2-one Hydrazones Containing Nitrophenyl or Isonicotinoyl/Nicotinoyl Moiety. Doan NQH; Tran HN; Nguyen NTM; Pham TM; Nguyen QDK; Vu TT Chem Biodivers; 2024 Oct; 21(10):e202401142. PubMed ID: 39032128 [TBL] [Abstract][Full Text] [Related]
18. Novel Hydrazone Derivatives of 3-Bromopyruvate: Synthesis, Evaluation of the Cytotoxic Effects, Molecular Docking and ADME Studies. Beygi F; Mostoufi A; Mojaddami A Chem Biodivers; 2022 Jun; 19(6):e202100754. PubMed ID: 35427437 [TBL] [Abstract][Full Text] [Related]